AdvaMed argues that the tax, which is scheduled to go into effect in January 2013, hurts research and development and slows hiring.
"Repealing the device tax is critical to medical innovation and job creation," AdvaMed spokesperson Wanda Moebius told the Alley. "Our sector is one of the few net exporters. We're a source of good, well-paying jobs and this tax is a tax on innovation."
AdvaMed has been lobbying on the issue and telling its members to contact their lawmakers about the medical device tax. It would not disclose the cost of the ad buy, but said that the ads will be tied to any committee or floor activity and would run through a floor vote.
DON'T MISS TODAY'S TOP STORIES
Chock full of usable information on today's issues."
Michael, Executive Director
Concise coverage of everything I wish I had hours to read about."
Chuck, Graduate Student
The day's action in one quick read."
Stacy , Director of Communications
Great way to keep up with Washington"
Ray, Professor of Economics